Tenaya Therapeutics, Inc. (TNYA)
0.7821
+0.04
(+4.68%)
USD |
NASDAQ |
Apr 17, 16:00
0.7657
-0.02
(-2.10%)
After-Hours: 05:23
Tenaya Therapeutics SG&A Expense (Quarterly) : 5.977M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 0.8466M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| Savara, Inc. | 12.53M |
| Vericel Corp. | 43.46M |
| BioMarin Pharmaceutical, Inc. | 446.21M |